LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models

Overview of attention for article published in Investigational New Drugs, December 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#48 of 1,167)
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

patent: 1 patent

googleplus: 10 Google+ users

Citations

dimensions_citation: 139 Dimensions

Readers on

mendeley: 99 Mendeley

Summary Patents Google+ Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

METHODS AND COMPOSITIONS FOR MODULATING HYPERSTABILIZED C-MET

Grant EP-1868648-B1

European Patent Office